Novartis in $1.68B Blood Unit Deal With Grifols

Nov. 11 (Bloomberg) -- Bloomberg’s Ryan Chilcote reports that Novartis has agreed to sell a blood transfusion diagnostics unit to Grifols for $1.68 billion in the company’s biggest asset sale in five years. He speaks on Bloomberg Television’s “The Pulse.”
A New Global Order of Cities: Ivo Daalder
14:35 - On “Morning Must Read,” Brendan Greeley recaps the op-ed pieces and analyst notes that provide insight into today's headlines. Eurasia Group President and Founder Ian Bremmer also speaks on “Bloomberg Surveillance.” (Source: Bloomberg)
  • The Bourbon You Are Drinking Might Not Be What You Think
  • Is U.S. Leadership Adrift on Foreign Policy?
  • Charlie Rose Brain Series 3: Episode 2 (05/27)